Previous studies have demonstrated that HS ameliorates myocardial ischemia/reperfusion (I/R) injury. Also, the differentially expressed proteins between HS and I/R groups were shown to be ...

In October, a preclinical coronary heart disease study demonstrated that the drug bestowed an 86% cardioprotection effect ...

We discovered that KLF15 coordinates cardiac catabolism and ROS clearance and regulates the circadian susceptibility of ischemia reperfusion injury by controlling cardiac NAD+. We are now studying the ...

Dihydromyricetin (Dih), a naturally occurring flavonoid, has been identified to exert a protective effect against ischemia/reperfusion injury. However, the detailed mechanisms remain unclear. Here we ...

Oppenheimer’s 35th Annual Healthcare Life Sciences Conference Please contact your Oppenheimer representative to request a one-on-one meeting with management.

who explored the capacity of epicatechin to reduce short-and long-term ischemia-reperfusion myocardial injury. Epicatechin (1 mg/kg) pre-treatment was administered daily via oral gavage to rodents ...